BRINTER

About:

Brinter - a Medtech platform company develops and manufactures 3D bioprinted bio-synthetic implants for tissue repairs / tendons management.

Website: https://www.brinter.com/

Twitter/X: WeAreBrinter

Top Investors: Innovestor

Description:

Brinter, a MedTech platform company, develops the first-ever series of 3D bioprinted bio-synthetic implants for the $4B soft tissue repair market. Starting with rotator cuff tears, we offer unprecedented patient benefits that are highly desirable in sports medicine, with the first implants coming in 2025. Our platform business model launches new implants for future orthopedic applications every two years.

Total Funding Amount:

$2.21M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Winston Salem, North Carolina, United States

Founded Date:

2020-01-01

Contact Email:

contact(AT)brinter.com

Founders:

Piira Marko, Tom Alapaattikoski, Tomi Kalpio

Number of Employees:

1-10

Last Funding Date:

2023-02-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai